Salmonella exploits NLRP12-dependent innate immune signaling to suppress host defenses during infection

Proceedings of the National Academy of Sciences of the United States of America
Md Hasan ZakiThirumala-Devi Kanneganti

Abstract

The nucleotide-binding oligomerization domain (NOD)-like receptor family pyrin domain containing 12 (NLRP12) plays a protective role in intestinal inflammation and carcinogenesis, but the physiological function of this NLR during microbial infection is largely unexplored. Salmonella enterica serovar Typhimurium (S. typhimurium) is a leading cause of food poisoning worldwide. Here, we show that NLRP12-deficient mice were highly resistant to S. typhimurium infection. Salmonella-infected macrophages induced NLRP12-dependent inhibition of NF-κB and ERK activation by suppressing phosphorylation of IκBα and ERK. NLRP12-mediated down-regulation of proinflammatory and antimicrobial molecules prevented efficient clearance of bacterial burden, highlighting a role for NLRP12 as a negative regulator of innate immune signaling during salmonellosis. These results underscore a signaling pathway defined by NLRP12-mediated dampening of host immune defenses that could be exploited by S. typhimurium to persist and survive in the host.

References

Jan 5, 2002·Microbes and Infection·L Eckmann, M F Kagnoff
Jan 7, 2003·The Journal of Biological Chemistry·Naohiro InoharaGabriel Nuñez
Jan 16, 2003·The Journal of Biological Chemistry·Stephen E GirardinPhilippe J Sansonetti
May 22, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kristi L WilliamsJenny P-Y Ting
Jun 7, 2003·Science·Stephen E GirardinDana J Philpott
May 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrés Vazquez-TorresFerric C Fang
Jun 11, 2004·Nature·Sanjeev MariathasanVishva M Dixit
Jul 29, 2006·Autophagy·Ashish C MasseyAna Maria Cuervo
Jul 11, 2007·Experimental Dermatology·Filippina MacalusoSabine Hoffjan
Oct 31, 2007·Immunity·Thirumala-Devi KannegantiGabriel Núñez
Jan 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·I JéruS Amselem
Feb 18, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shannon E MajowiczUNKNOWN International Collaboration on Enteric Disease 'Burden of Illness' Studies
Jul 7, 2010·The Journal of Experimental Medicine·Petr BrozDenise M Monack
Jun 16, 2011·The Journal of Infectious Diseases·Casey Barton BehraveshUNKNOWN FoodNet Working Group
Nov 19, 2011·Cancer Cell·Md Hasan ZakiThirumala-Devi Kanneganti
Dec 27, 2011·Immunity·Mandy McGeachy
Jul 6, 2012·Nature·Paras K AnandThirumala-Devi Kanneganti
Jul 31, 2012·Immunity·Gregory I VladimerEgil Lien
Aug 14, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jieling YangFeng Shao

❮ Previous
Next ❯

Citations

Jul 30, 2014·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Stephan BorteAlisan Yildiran
May 20, 2014·Seminars in Immunopathology·John R Lukens, Thirumala-Devi Kanneganti
Jan 13, 2016·Trends in Immunology·Christoph A ThaissEran Elinav
Aug 5, 2015·Proceedings of the National Academy of Sciences of the United States of America·Jennifer L KraussDeborah V Novack
Mar 10, 2016·Proceedings of the National Academy of Sciences of the United States of America·Gennaro Di PriscoFrancesco Pennacchio
Aug 22, 2015·Cellular Microbiology·Kaiyi ZhangAline Dupont
Aug 27, 2014·The FEBS Journal·Hanne Van GorpMohamed Lamkanfi
Apr 17, 2015·Immunological Reviews·Si Ming Man, Thirumala-Devi Kanneganti
Jul 30, 2014·Cytokine & Growth Factor Reviews·François BarbéMaya Saleh
Jan 15, 2016·The Journal of General Virology·Sheryl Coutermarsh-OttIrving Coy Allen
May 6, 2014·Frontiers in Immunology·Irving Coy Allen
Feb 6, 2015·Frontiers in Microbiology·Agnès WiedemannPhilippe Velge
Oct 16, 2014·Seminars in Immunopathology·Maayan LevyEran Elinav
Jun 22, 2016·The Journal of Cell Biology·Deepika Sharma, Thirumala-Devi Kanneganti
Jan 15, 2015·Trends in Immunology·Judith BehnsenManuela Raffatellu
Nov 2, 2016·European Journal of Immunology·Tatiana N SilveiraSergio C Oliveira
Apr 13, 2017·Mucosal Immunology·N ZmoraE Elinav
Jul 25, 2017·Cellular & Molecular Immunology·Jenny Moi-Fong Lau, Yvonne Dombrowski
Aug 26, 2014·Inflammatory Bowel Diseases·Beckley K DavisIrving C Allen
Mar 4, 2018·Rheumatology International·Mikhail M KostikEvgeny N Imyanitov
Feb 6, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Brandon M L LinzRobert Maile
Feb 2, 2018·Journal of Leukocyte Biology·Daniel E RothschildIrving C Allen
Oct 26, 2016·Nature Communications·Tyler K UllandFayyaz S Sutterwala
Dec 29, 2015·Cellular and Molecular Life Sciences : CMLS·Nidhi Sharma, Sushmita Jha
Jul 3, 2019·Cellular Microbiology·Nathaniel WinsorStephen E Girardin
Jul 12, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Matsayapan PudlaPongsak Utaisincharoen
Jul 14, 2020·Immunological Reviews·Timur LiwinskiEran Elinav
Sep 25, 2014·Journal of Leukocyte Biology·Sinem TuncerRosa Sorrentino
Feb 14, 2017·Frontiers in Immunology·Carlos de Torre-MinguelaPablo Pelegrín
Oct 14, 2017·Immunological Reviews·Deepika Sharma, Thirumala-Devi Kanneganti
Mar 30, 2018·Frontiers in Cellular and Infection Microbiology·Lidan WangShuyan Wu
Oct 16, 2018·Frontiers in Immunology·Jingyun Luan, Dianwen Ju
Sep 22, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gwendolyn M ClayMary E Wilson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.